
Adglim MP LS 1mg/500mg/7.5mg Tablet
Marketer
Cadomed Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Adglim MP LS 1mg/500mg/7.5mg Tablet
Adglim MP LS 1mg/500mg/7.5mg tablets combine medications to effectively manage blood glucose. This medication, used alongside diet and exercise, enhances blood sugar control in adults with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Dosage and frequency of Adglim MP LS 1mg/500mg/7.5mg tablets should strictly follow your physician's instructions. Ingestion with food minimizes stomach irritation. Missed doses should be taken promptly; however, if nearing the next scheduled dose, omit the missed one and resume your usual regimen. Never double the dose. Excessive medication can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk. Regular blood glucose monitoring is crucial. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be assessed before treatment begins. Limit alcohol consumption as it may heighten side effect probability.
Uses of Adglim MP LS 1mg/500mg/7.5mg Tablet
Managing type 2 diabetes
Major Benefits of Adglim MP LS 1mg/500mg/7.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Adglim MP LS 1mg/500mg/7.5mg Tablet whole; avoid chewing, crushing, or breaking it. It should be administered with food.
Common Side effects of Adglim MP LS 1mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Adglim MP LS 1mg/500mg/7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Adglim MP LS 1mg/500mg/7.5mg tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Adglim MP LS 1mg/500mg/7.5mg Tablet works:
Adglim MP LS tablets (1mg/500mg/7.5mg) combine glimepiride, metformin, and pioglitazone to improve blood sugar management when other treatments are insufficient. This triple-drug approach utilizes distinct mechanisms: glimepiride (a sulfonylurea) stimulates pancreatic insulin release; metformin (a biguanide) reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness; and pioglitazone (a thiazolidinedione) further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Adglim MP LS 1mg/500mg/7.5mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Adglim MP LS 1mg/500mg/7.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Adglim MP LS 1mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Adglim MP LS 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with hepatic impairment should use Adglim MP LS 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Adglim MP LS 1mg/500mg/7.5mg tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Adglim MP LS 1mg/500mg/7.5mg Tablet :
Should you forget to take your Adglim MP LS 1mg/500mg/7.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Adglim MP LS 1mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
